You may also like
Effective Use of Reporting Guidelines to Improve the Quality of Surgical Research
Surgical investigators must continue to raise the bar for research across all specialties and aim for the highest standards by which evidence for surgical interventions is evaluated and disseminated. The routine use of reporting standards represents another incremental step toward meeting these goals.
Bayer Pulls Trasylol From Market
Bayer HealthCare Pharmaceuticals Inc. has notified the FDA that the company will begin removing the remaining Trasylol stock from the U.S. market, most of which is in warehouses and hospital or physician’s stock. The FDA will work with Bayer to ensure a smooth and complete process.
Novel Use of Cangrelor with Heparin During Cardiopulmonary Bypass in Patients with Heparin-induced Thrombocytopenia who Require Cardiovascular Surgery: A Case Series
Optimal anticoagulation strategy during cardiopulmonary bypass (CPB) remains uncertain in patients with heparin-induced thrombocytopenia (HIT) who require urgent/emergent cardiac surgery.
